期刊
DRUG DISCOVERY TODAY
卷 23, 期 5, 页码 934-943出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2017.08.012
关键词
-
资金
- Ministry of Science and Technology of Taiwan [104-2314-B-038-040-MY3]
- 'Aim for the Top University Plan' of the Taipei Medical University
- Ministry of Education, Taiwan
Circulating blood cells, and cell-derived microvesicles, are emerging as pragmatic delivery systems that can smartly complement the already existing nanotherapeutic platforms evaluated to treat or diagnose diseases. The valuable distinctive features of circulatory cells over synthetic nanocarriers encompass their biological origin which confers immune transparence, known biodegradability, high drug loading, relatively long half-life and a targeting capacity associated with their physiological surface functionality. Absence of nuclei in red blood cells and platelets provides further rationale for their use as cargo vehicles for nucleotoxic agents. Ongoing developments in cell-based and cell-inspired nanotherapies can move drug delivery into reachable frontiers and exhibit high potentiality for translatability into clinical use.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据